This page is KiTalent's market intelligence on hiring in Linköping's medtech and medical IT sector. It separates what the public record establishes from what no published source measures, because a hiring decision in this market has to be built on that distinction. Everything below is anchored in sources a buyer can check, listed at the end; where the record stops, we say so.
The buyer question
You are hiring in or around Linköping for a role the region's own assessment describes as its weak supply side: senior and specialist competence. Region Östergötland's 2026 mapping of the county's life science sector, commissioned by the region's development unit and built on Vinnova's company population, puts it in one sentence: competence supply is good at junior level but weaker at senior and specialised level. The buyer question is therefore not whether Linköping produces talent. It does, at scale, through one of Sweden's largest technical universities and the ecosystem around it. The question is what it takes to hire the senior specialists that the two anchor companies, the university hospital and the small-company layer all compete for, when the regional record shows employment growing far more slowly than the business it supports.
What the public record shows
The county's life science sector consists of 86 companies with activity in Östergötland, 80 of them headquartered there, on Vinnova's population as compiled in the regional mapping. More than 90 percent of the sector's employment sits in medical technology, and two companies, Sectra and Cambio, account for a significant share of that employment. The absolute majority of the county's life science workplaces have fewer than ten employees, and nearly half have none at all. More than 90 percent of the sector's employees and 60 percent of its companies are located in Linköping municipality. Sized against the rest of the country, Östergötland's sector stands at the level of Västerbotten and Halland, far behind Stockholm, Västra Götaland and Uppsala, but well ahead of most counties.
The growth-versus-workforce tension in this market is documented, not rhetorical. The mapping records that the sector's turnover has developed positively over the last four years, with especially fast growth from 2022 onward, while employment has also increased, but more slowly than turnover. Since 2009 the county's life science employment has grown around 14 percent, roughly ten percentage points slower than Västerbotten and Örebro and nearly thirty points slower than Halland. A sector whose revenue compounds faster than its headcount is, by definition, raising the bar it places on the people it already employs, and on every senior hire it needs to make.
Sectra AB is the clearest product of the region's ecosystem. Founded in 1978 and headquartered in Linköping, with direct sales in 19 countries, the Sectra Group reports some 1,100 employees worldwide. In its 2025/26 fiscal year, net sales increased 9.3 percent to SEK 3,541.7 million, or 16.5 percent at unadjusted exchange rates, with recurring revenue up 18.6 percent. The regional mapping credits Sectra with having created a critical mass of competence in image analysis, software development and clinical IT that has acted as a magnet for both talent and new companies; AMRA, SyntheticMR and ContextVision grew out of the same technical and clinical ecosystem. Cambio, founded in 1993 by two students from Linköping, is today around 900 employees across several countries and one of the Nordic region's leading actors in care information systems, with its development operations in Linköping. Its COSMIC care information system is used, or being implemented, by 17 of Sweden's 21 regions, and more than 120 municipalities use the group's services.
The research base underneath the cluster is real and specific. Linköping University, with 46,200 students and 4,700 employees, hosts the research environments the mapping singles out: medical technology, image analysis and AI. Universitetssjukhuset i Linköping contributes clinical research and test environments, although the mapping notes that access varies between operations. The Analytic Imaging Diagnostics Arena, a Vinnova-funded national arena for research and innovation in AI for medical image analysis, is hosted in this ecosystem and is named in the mapping as part of the region's innovation support together with the science parks, incubators and RISE. Linköping Science Park describes itself as home to more than 600 companies and over 7,000 people. The mapping's structural diagnosis is worth reading in full: strong research, technology and company-driven innovation, but an identity gap in that the region lacks a shared story, an organisation gap in that no formal cluster organisation exists, strong informal networks with weak systematics, a capital gap clearest in biotech and clinically heavy projects, and weak global visibility for the region as a whole.
What changes in this market
Three verified changes frame hiring in 2026.
First, the MDR certification window is open, but closing. Under Regulation (EU) 2023/607, legacy Class III and implantable Class IIb devices may be placed on the market until 31 December 2027, and other certified legacy devices until 31 December 2028, conditional on manufacturers having applied to a notified body and put the required quality-system upgrades in place. For every certified device line in the region's small-company layer, regulatory-affairs and quality-system competence therefore stays in demand through at least 2028, and the burden concentrates on precisely the smallest workplaces that make up most of this county's sector.
Second, Sweden's cybersecurity law changed the compliance perimeter for healthcare operators. The NIS2 directive entered Swedish law through a new cybersecurity act on 15 January 2026, Sweden having implemented after the EU's October 2024 deadline. The law covers essential and important operators across 18 sectors, healthcare among them, and requires them to report incidents that cause or could cause significant disruption, to maintain systematic cybersecurity work, and to train management and staff. For a region whose medtech cluster is overwhelmingly software and clinical IT, that is a demand signal for security competence attached to exactly the systems Linköping's companies build and run. It binds operators, not device manufacturers as such, whose reporting obligations sit in the medical-device regulations instead.
Third, the international competition for specialists has a tax address. Denmark's researcher tax scheme offers qualifying researchers and highly paid specialists a flat 27 percent tax on employment income, plus the 8 percent labour-market contribution, roughly a 33 percent effective rate, for up to 84 months. For a specialist who can work in either country, a Linköping offer is written against that regime as much as against Swedish salary levels. It does not empty Linköping of talent, but international packages in this market are negotiated knowing Copenhagen is one bridge away.
KiTalent's mandate analysis
Read as a hiring market, the verified record points to one conclusion: this is a seniority problem, not a volume problem. The region graduates junior technical talent at scale and its anchor companies train it; what the mapping says the region lacks is senior and specialised competence, precisely the layer a leadership hire lives in. That has practical consequences for a mandate here. Define the seniority evidence as owned outcomes rather than years of service. Expect regulatory and quality-system work to run through the 2027 to 2028 certification window. Treat clinical-plus-machine-learning hybrid profiles as scarce everywhere, not just locally. Benchmark total offers against Stockholm and, for internationally mobile candidates, against the Danish researcher-tax regime.
For organisations competing for regulatory, AI and clinical-data leadership in Linköping's medtech market, speak with our executive search team about how we approach this market differently.
Where the public record stops
Several questions a buyer will ask have no published answer, and a search process in this market should treat them as measurements to commission rather than facts to assume:
- No published compensation series locates Linköping medtech pay against Stockholm; salary benchmarking needs current market data at mandate time.
- No public statistic measures vacancy duration, search-failure rates or the share of passive candidates for this market.
- No county-level allocation of Swedish medtech venture capital is published.
- No public record counts senior specialists by discipline in the county, projects retirement among clinical engineers and medical physicists, or states a Linköping-Stockholm housing-cost differential in a form a compensation plan can cite.
These gaps are where an executive-search process earns its fee: the numbers are built for the mandate, not quoted at it.
Sources
Sources read for this page, retrieved 11 October 2026:
- Region Östergötland and WSP, Kartläggning av life science i Östergötland, regional mapping report, 2026.
- Sectra AB, year-end report 2025/2026, press release, Linköping, 5 June 2026.
- Sectra Group, news and press releases, company boilerplate, sectra.com.
- Cambio Group, About us, cambiogroup.com.
- NCSC Sverige, Det här är cybersäkerhetslagen, ncsc.se.
- Regulation (EU) 2023/607 extending the MDR transitional periods.
- Danish Tax Agency, researcher tax scheme (forskerordningen), skat.dk.
- Linköping Science Park, About us, linkopingsciencepark.se.
- Linköping University, LiU i siffror, liu.se.
- Visual Sweden and Medtech4Health on the Analytic Imaging Diagnostics Arena.
Related KiTalent research
- Linköping
- Sweden
- Healthcare Life Sciences
- Uppsala Digital Health Talent: What the Verified Record Shows
- Stockholm AI and Cloud: Define the Platform and Scaling Mandate
- Malmo Logistics Talent Drain: What the Verified Record Shows
- Milan Fashion Hiring: Separate Brand, Industrial and Supply-Chain Leadership
How this page was produced
This page combines KiTalent market intelligence, direct-search methodology, and primary market sources where available.
